- Home
- LAW vs EMBC Comparison
LAW vs EMBC Comparison
Compare LAW & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAW
- EMBC
- Stock Information
- Founded
- LAW 2013
- EMBC 1924
- Country
- LAW United States
- EMBC United States
- Employees
- LAW N/A
- EMBC N/A
- Industry
- LAW Computer Software: Prepackaged Software
- EMBC Medical/Dental Instruments
- Sector
- LAW Technology
- EMBC Health Care
- Exchange
- LAW Nasdaq
- EMBC Nasdaq
- Market Cap
- LAW N/A
- EMBC 719.1M
- IPO Year
- LAW 2021
- EMBC N/A
- Fundamental
- Price
- LAW $3.98
- EMBC $11.50
- Analyst Decision
- LAW Hold
- EMBC Buy
- Analyst Count
- LAW 3
- EMBC 2
- Target Price
- LAW $6.17
- EMBC $19.00
- AVG Volume (30 Days)
- LAW 85.5K
- EMBC 653.5K
- Earning Date
- LAW 05-08-2025
- EMBC 05-08-2025
- Dividend Yield
- LAW N/A
- EMBC 5.17%
- EPS Growth
- LAW N/A
- EMBC 2.96
- EPS
- LAW N/A
- EMBC 0.99
- Revenue
- LAW $144,841,000.00
- EMBC $1,107,700,000.00
- Revenue This Year
- LAW $5.43
- EMBC N/A
- Revenue Next Year
- LAW $5.64
- EMBC $0.99
- P/E Ratio
- LAW N/A
- EMBC $11.62
- Revenue Growth
- LAW 4.89
- EMBC N/A
- 52 Week Low
- LAW $3.52
- EMBC $9.93
- 52 Week High
- LAW $8.24
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- LAW 27.95
- EMBC 29.80
- Support Level
- LAW $3.98
- EMBC $11.33
- Resistance Level
- LAW $4.23
- EMBC $12.63
- Average True Range (ATR)
- LAW 0.16
- EMBC 0.61
- MACD
- LAW -0.03
- EMBC 0.01
- Stochastic Oscillator
- LAW 19.70
- EMBC 12.92
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.